FindTrial
Sign In

G-CSF Plus Plerixafor

DRUG8 trials

Sponsors

Genzyme, a Sanofi Company, Duke University

Conditions

Autologous Stem Cell TransplantationHodgkin DiseaseHodgkin's DiseaseHodgkins DiseaseLymphoma, Non-HodgkinLymphoma, Non-Hodgkin'sMultiple MyelomaNon-Hodgkin Lymphoma

Phase 2

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
CompletedNCT00322491
Genzyme, a Sanofi CompanyLymphoma, Non-Hodgkin, Multiple Myeloma
Start: 2004-03-31End: 2006-06-30Updated: 2014-03-13
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
CompletedNCT00322842
Genzyme, a Sanofi CompanyLymphoma, Non-Hodgkin, Multiple Myeloma
Start: 2004-09-30End: 2007-02-28Updated: 2014-03-13
AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone
TerminatedNCT00395967
Genzyme, a Sanofi CompanyLymphoma, Non-Hodgkin's, Multiple Myeloma
Start: 2005-04-30End: 2006-08-31Updated: 2015-05-01
AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF
CompletedNCT00396266
Genzyme, a Sanofi CompanyLymphoma, Non-Hodgkin, Multiple Myeloma
Start: 2005-01-31End: 2007-12-31Updated: 2014-03-07
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
CompletedNCT00396201
Genzyme, a Sanofi CompanyHodgkin's Disease
Start: 2004-11-30End: 2008-01-31Updated: 2014-03-13
AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts
CompletedNCT00396331
Genzyme, a Sanofi CompanyAutologous Stem Cell Transplantation
Start: 2005-10-31End: 2009-12-31Updated: 2014-03-13
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)
CompletedNCT00444912
Genzyme, a Sanofi CompanyHodgkin Disease, Non-Hodgkin Lymphoma
Start: 2006-02-28End: 2009-06-30Updated: 2014-03-13
Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant
CompletedNCT00901225
Duke UniversityHodgkins Disease, Multiple Myeloma, Non-Hodgkins Lymphoma
Start: 2009-05-31End: 2013-05-31Updated: 2014-05-07